1 They concluded that “TENS is established as ineffective” for chronic low back pain (LBP), based on an analysis of two Class I randomized controlled trials (RCTs) with a total of 114 ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...